(Q39429017)

English

The role of the GAVI Alliance in improving childhood hepatitis B vaccination in China: successes, lessons learned, and future global challenges

scientific article published on 24 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

The role of the GAVI Alliance in improving childhood hepatitis B vaccination in China: successes, lessons learned, and future global challenges (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

lessons learned

1 reference

based on heuristic

inferred from title

author name string

Francisco Averhoff

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Amy Kolwaite

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

John W Ward

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

language of work or name

0 references

publication date

24 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

31 Suppl 9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

J5-7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Epidemiological serosurvey of hepatitis B in China--declining HBV prevalence due to hepatitis B vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.022

7 January 2021

Major causes of death among men and women in China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.022

7 January 2021

The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.022

7 January 2021

Estimation and projection of the national profile of cancer mortality in China: 1991-2005

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.022

7 January 2021

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.022

7 January 2021

Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.022

7 January 2021

A mathematical model to estimate global hepatitis B disease burden and vaccination impact.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.022

7 January 2021

China's facility-based birth strategy and neonatal mortality: a population-based epidemiological study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.022

7 January 2021

Origins, design and implementation of the China GAVI project

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.022

7 January 2021

The impact of hepatitis B vaccine in China and in the China GAVI Project

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.04.022

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.04.022

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39429017&oldid=1827491529"